摘要:
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要:
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要:
Compounds of formula (I) and their pharmaceutically acceptable salts are described: formula (I). Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要:
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要:
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要:
Compounds of formula (I) and their pharmaceutically acceptable salts are described: Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要:
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要:
A system for managing database logging, the comprises a processor; and a user task executing in a database server process and executable by the processor, the user task to: receive in a database management system on a database server, a command to manipulate a portion of a database managed by the database management system; obtain a lock on the portion of the database; create a first log record in a first private log cache associated with the user task, the first log record recording a data manipulation to the portion of the database; enqueue the first log record to a queue; and release the lock on the portion of the database after copying the first log record to the queue.
摘要:
The present invention provides a method and an apparatus for power supply control as well as an electronic device. The method comprises: detecting that the first device is connected with the second device via the first physical interface, when the first device is in the unconnected state; determining whether the connection between the first and second devices satisfies a first predetermined condition or not, so as to obtain a first determination result; switching the first device from the unconnected state to the first connected state when the first determination result indicates that the connection satisfies the first predetermined condition; obtaining power supply requirement information of the second device that indicates whether the first device is required to supply power to the second device or not; and controlling the power supply to the second device via the first physical interface based on the power supply requirement information.
摘要:
A compound of the formula (I), or a pharmaceutically-acceptable salt, or in-vivo hydrolysable ester thereof: Wherein C is selected from (D) and (E), R2a, R6a, and R3a are independently selected from for example H, CF3, Me and Et; R2b and R6b are independently selected from for example H, F, CF3, Me and Et; R1b is for example optionally substituted diazolyl, triazolyl or tetrazolyl; R4 is for example an optionally substituted 5- or 6-membered heterocyclic ring system. Methods for making compounds of the formula (I), compositions containing them and their use as antibacterial agents are also described.
摘要翻译:式(I)化合物或其药学上可接受的盐或其体内可水解的酯:其中C选自(D)和(E),R 2a,R 6a和R 3a独立地选自例如H ,CF3,Me和Et; R2b和R6b独立地选自H,F,CF3,Me和Et; R 1b是例如任选取代的二唑基,三唑基或四唑基; R4是例如任选取代的5元或6元杂环系。 还描述了制备式(I)化合物,含有它们的组合物及其作为抗菌剂的用途的方法。